Biofrontera Inc. (NASDAQ:BFRI) Sees Large Decrease in Short Interest

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 316,600 shares, a decrease of 30.7% from the October 31st total of 457,100 shares. Approximately 7.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,780,000 shares, the days-to-cover ratio is presently 0.1 days.

Biofrontera Stock Down 9.1 %

BFRI opened at $0.90 on Friday. The stock has a market capitalization of $6.98 million, a price-to-earnings ratio of -0.40 and a beta of 0.50. Biofrontera has a twelve month low of $0.61 and a twelve month high of $4.00. The company has a 50-day simple moving average of $0.94 and a 200 day simple moving average of $1.04.

Analysts Set New Price Targets

Separately, Benchmark reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a report on Friday, November 15th.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.